Larvol Delta - A-Phase-2-Randomized-DoubleBlind-PlaceboControlled-Study-to-Assess-the-Efficacy-Safety-and-Tolerability-of-ANJ908-a-Novel-DGAT1-Inhibitor-in-Patients-With-Chronic-Idiopathic-Constipation

pradigastat (LCQ908) - Novartis

https://www.eventscribe.net/2022/ACG-Posters/ajaxcalls/PosterInfo.asp?efp=VlZRRFFHSk4xNzEyNg&PosterID=515247&rnd=0.6724276

Dan Meyers, MD 1; May Li, 2; Ming Yang, MD 2

Sep 4, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next